Answers are grounded in this paper and cite their sources.
Ten groups of commonly utilized medications were examined both in vitro and in vivo for their ability to interfere with optical density measurement and/or color development in such routine endocrine laboratory tests as those for 17-ketosteroids and 17-hydroxycorticosteroids. Certain antihypertensives, tranquilizers, psychic energizers, monoamine oxidase inhibitors, and soporifics were found to create the most problems in interference. The importance of removing these medications from the patients' therapeutic regimes prior to obtaining specimens for such endocrine procedures is stressed.
No takes yet. Share an insight, caveat, or question.
Borushek et al. (1964) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: